Navigation Links
InspireMD To Participate In Benchmark Investor Conference On May 30th
Date:5/24/2013

ative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabilities and reliance on subcontractors for assistance, (vii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (viii) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (ix) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (x) our reliance on single suppliers for certain product components, (xi) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Transition Report on Form 10-K/T and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

For additional information:
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. InspireMD Hires Vice President of Corporate Development
2. Michael Berman Joins InspireMD Board
3. InspireMD Postpones $40 Million Registered
4. InspireMD Reports 2012 Fiscal Year Results
5. InspireMD to Present at JMP Securities Healthcare Conference on July 12th in New York
6. InspireMD to Present at JMP Securities Healthcare Conferenceon July 12th in New York
7. InspireMD Appoints Dr. James Barry to Its Board of Directors
8. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
9. ViroPharma To Participate In Two May Healthcare Investor Conferences
10. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
11. AVANIR Pharmaceuticals To participate in two conferences in March
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... 2015 , ... The next-generation sequencing (NGS) clinical market is poised for huge ... industry. BCC Research reveals in its new report that the market drivers of this ... growing need for better diagnostics as part of a molecular diagnostics trend. , The ...
(Date:7/1/2015)... HAMILTON, Bermuda , July 1, 2015 /PRNewswire/ ... biopharmaceutical company focused on the treatment of dementia, ... investor briefing on July 22 at 5:45 p.m. ... at the Alzheimer,s Association International Conference 2015 (AAIC). ... following remarks: , Dr. Lawrence ...
(Date:7/1/2015)... PHILADELPHIA , July 1, 2015 ... technology will ... s evidence-based clinical s olutions suite ... scientific, technical and medical information products and services, announced today ... -based clinical decision support (CDS) technology company. InferMed,s ...
(Date:7/1/2015)... 1, 2015  UCB, a multinational biopharmaceutical company, ... leader in designing, transforming, and running intelligent business ... recognition of their close collaboration in driving transformation ... business services (GBS) finance organization. The ... that work together effectively to embrace the innovative ...
Breaking Biology Technology:NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... Fluorescence activated cell sorting (FACS) is a , tool ... individual cells using fluorescent probes that bind specifically to molecules , ... cells of a given population down to the level of a ... Figure 1.Linear Amplification from 1-1000 Cells. , ...
... Isolate and Enrich for ... Isolating Bacterial RNA for Microarray Analysis , The rapid increase in , ... several years has opened up a new ... analysis using DNA microarray technology. In recent , ...
... NEW Cyanobacterial Module , ... MICROB Express (patent pending) is currently the , ... novel strategy that rapidly removes >95% of the 16S and 23S rRNA from , ... species , (Figure 1). MICROB Express can ...
Cached Biology Technology:Cells-to-cDNA II Using FACS Sorted Cells 2Bacterial Whole Genome Array Analysis 2Bacterial Whole Genome Array Analysis 3Bacterial Whole Genome Array Analysis 4Bacterial Whole Genome Array Analysis 5Bacterial Whole Genome Array Analysis 6Bacterial Whole Genome Array Analysis 7Bacterial mRNA Isolation, Fast and Easy 2Bacterial mRNA Isolation, Fast and Easy 3
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/16/2015)... CITY , June 16, 2015 /CNW Telbec/ ... their partnership centralized around the incorporation of handyem,s ... point-of-care diagnostic laboratory, the Mo-POD™. This unprecedented model ... BIO International Conference at the Pennsylvania ... from June 15 th to 18 ...
(Date:6/15/2015)... 2015 A new report [ ... majority of US consumers using mobile banking applications want their ... fingerprint and voiceprint, instead of having to prove who they ... " Mobile Identity   -   The Fusion of Financial ... now the primary channel used by Gen X and Gen ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... damage that normally heals on its own will not ... land that release industrial chemicals, fuel oils and other ... colleagues have found. , UCF associate professor of biology ... Institute, Broward County Department of Environmental Protection, the College ...
... Wolbachia have long been interested in its ability to proliferate. ... of its insect hosts and genetically tricking them to bear ... Now, a new study from the MBL (Marine Biological ... demonstrates that a virus common to Wolbachia cells may be ...
... Neuroscientists at the Case Western Reserve University School ... in the brain's immune cells triggers a cascade ... that eventually leads to the neural cell death ... their findings in the Journal of Biological Chemistry ...
Cached Biology News:Pollution threatens coral health by preventing lesions from healing, UCF study shows 2Pollution threatens coral health by preventing lesions from healing, UCF study shows 3Viral hitchhiker inhibits Wolbachia bacteria's ability to proliferate 2Case Western Reserve University researchers find protein associated with brain cell death 2
... emerging as a powerful new tool for ... only amino groups have been able to ... as our Sulfo-SBED. Sulfhydryl-reactive Mts-Atf-Biotin and its ... to the protein interaction tool chest that ...
... a compact benchtop and stackable multi-function ... with a large display screen to ... Air circulation inside to evenly distribute ... be easily calibrated from the microprocessor ...
... Nonanoyl-N-methylglucamide White solid. ... be readily removed by dialysis. Useful ... ≥98% by HPLC. Absorbance (10%, ... 2 O. CMC 19 - 25 ...
...
Biology Products: